Yoshiyuki Yamamoto Selected Research

Axitinib (AG 013736)

1/2024	Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy.
4/2022	[A Case of Pleural Empyema with Fistula Caused by Endobronchial Metastasis of Renal Cell Carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiyuki Yamamoto Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 09/2011
16	Stomach Neoplasms (Stomach Cancer) 10/2023 - 07/2014
14	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 12/2011
13	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 09/2012
13	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 01/2013
12	Neoplasm Metastasis (Metastasis) 02/2024 - 11/2018
12	Carcinoma (Carcinomatosis) 05/2022 - 09/2011
6	Urinary Bladder Neoplasms (Bladder Cancer) 05/2023 - 09/2011
5	Ascites 10/2023 - 01/2017
5	Lymphatic Metastasis 03/2023 - 09/2012
4	Adenocarcinoma 07/2023 - 01/2014
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023 - 05/2015
4	Disease Progression 05/2023 - 01/2021
3	Fever (Fevers) 08/2022 - 01/2013
2	Margins of Excision 02/2024 - 10/2017
2	Hepatitis 01/2024 - 09/2021
2	Body Weight (Weight, Body) 10/2023 - 12/2016
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2023 - 12/2020
2	Hyperthermia 07/2023 - 01/2019
2	Signet Ring Cell Carcinoma 04/2023 - 01/2022
2	Anemia 01/2023 - 08/2022
2	Hemorrhage 04/2022 - 09/2013
2	Fistula 04/2022 - 09/2010
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Erythema 11/2018 - 02/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2015 - 01/2013
2	Cardiotoxicity 07/2014 - 07/2013
1	Abdominal Pain (Pain, Abdominal) 01/2024
1	Cytokine Release Syndrome 01/2024
1	Neuroendocrine Carcinoma 10/2023
1	Proteinuria 05/2023
1	Renal Insufficiency (Renal Failure) 04/2023
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 04/2023

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2016
11	NivolumabIBA 10/2023 - 01/2021
8	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 02/2019
8	Bevacizumab (Avastin)FDA Link 03/2024 - 10/2019
6	Cell-Free Nucleic AcidsIBA 01/2024 - 04/2018
6	Circulating Tumor DNAIBA 05/2022 - 02/2019
5	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
5	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 03/2014
4	Monoclonal AntibodiesIBA 10/2023 - 12/2015
4	RamucirumabIBA 10/2023 - 04/2022
4	MicellesIBA 12/2016 - 07/2013
4	Thromboplastin (Tissue Factor)IBA 03/2016 - 05/2015
4	NC 6300IBA 03/2016 - 07/2013
3	cabazitaxel FDA Link 04/2024 - 07/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 10/2019
3	trifluridine tipiracil drug combinationIBA 03/2024 - 01/2023
3	pembrolizumabIBA 01/2024 - 10/2021
3	Immunoglobulin G (IgG)IBA 10/2023 - 12/2015
3	Gemcitabine FDA Link 07/2023 - 11/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2022 - 01/2021
3	Epirubicin (Ellence)FDA LinkGeneric 03/2016 - 07/2013
2	Bacterial DNAIBA 04/2024 - 09/2023
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 10/2019
2	Leucovorin (Folinic Acid)FDA Link 03/2024 - 01/2022
2	Axitinib (AG 013736)IBA 01/2024 - 04/2022
2	Protons (Proton)IBA 07/2023 - 10/2021
2	130-nm albumin-bound paclitaxelIBA 07/2023 - 01/2017
2	Therapeutic UsesIBA 03/2023 - 03/2022
2	Albumin-Bound Paclitaxel FDA Link 12/2022 - 04/2022
2	Capecitabine (Xeloda)FDA Link 08/2022 - 11/2020
2	AndrogensIBA 07/2022 - 10/2013
2	IpilimumabIBA 04/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2022
2	AlbuminsIBA 10/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 07/2021 - 02/2019
2	MicroRNAs (MicroRNA)IBA 04/2021 - 10/2013
2	Interleukin-6 (Interleukin 6)IBA 03/2019 - 01/2018
2	AgarIBA 01/2019 - 12/2002
2	Panitumumab (Vectibix)FDA Link 02/2015 - 01/2013
1	16S Ribosomal RNAIBA 04/2024
1	afliberceptIBA 03/2024
1	tocilizumab (atlizumab)FDA Link 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 01/2024
1	HaptoglobinsIBA 10/2023
1	avelumabIBA 04/2023
1	nedaplatinIBA 04/2023
1	enzalutamideIBA 03/2023
1	taxaneIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Alkaline PhosphataseIBA 12/2022

Therapy/Procedure

27	Drug Therapy (Chemotherapy) 10/2023 - 12/2011
21	Therapeutics 01/2024 - 12/2011
6	Castration 04/2024 - 07/2019
6	Prostatectomy (Retropubic Prostatectomy) 02/2024 - 07/2014
5	Radiotherapy 10/2023 - 12/2011
4	Nephrectomy 01/2024 - 09/2012
4	Cystectomy 05/2023 - 09/2011
3	Adjuvant Chemotherapy 01/2019 - 07/2013
2	Proton Therapy 07/2023 - 10/2021
2	Urinary Diversion (Ileal Conduit) 05/2023 - 09/2011
2	Neoadjuvant Therapy 05/2023 - 10/2021
2	Immunotherapy 01/2023 - 04/2022
2	Chemoradiotherapy 10/2021 - 10/2020
2	Nephroureterectomy 11/2015 - 02/2015
2	Kidney Transplantation 02/2013 - 02/2013
1	Precision Medicine 02/2024
1	Drug Tapering 01/2024